Logo for Xtant Medical Holdings Inc

Xtant Medical Investor Relations Material

Latest events

Logo for Xtant Medical Holdings Inc

Q3 2024

Xtant Medical
Logo for Xtant Medical

Q3 2024

12 Nov, 2024
Logo for Xtant Medical

Q2 2024

9 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Xtant Medical Holdings Inc

Access all reports
Xtant Medical Holdings Inc develops and manufactures regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The Company's OsteoSponge biomaterial is a natural scaffold used to promote bone formation or repair. Its other products include OsteoStop, an autologous cell therapy that induces a pro-inflammatory response to reduce endothelial cell activation, OsteoSelect DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor cream that contains various proteins and peptides that support bone formation and remodeling.